Related Experiment Videos
On-line synthesis utilizing immobilized enzyme reactors based upon immobilized dopamine beta-hydroxylase
Nektaria Markoglou1, Irving W Wainer
1Department of Medicine, McGill University, Montreal, Quebec, Canada.
Summary
New immobilized enzyme reactors (IMERs) using dopamine beta-hydroxylase (DBH) were created. These DBH-IMERs enable on-line characterization of enzyme forms and drug candidate discovery.
Area of Science:
- Biochemistry and Enzymology
- Analytical Chemistry
- Drug Discovery
Background:
- Dopamine beta-hydroxylase (DBH) is crucial in neurotransmitter synthesis.
- Characterizing cytosolic and membrane-bound DBH forms presents challenges.
- Immobilized enzyme reactors (IMERs) offer a platform for enzyme analysis.
Purpose of the Study:
- To develop and characterize novel immobilized enzyme reactors (IMERs) for dopamine beta-hydroxylase (DBH).
- To investigate the on-line hydroxylation activity of DBH immobilized on different stationary phases.
- To establish a coupled chromatographic system for characterizing DBH enzyme-substrate and enzyme-inhibitor interactions.
Main Methods:
- Immobilization of DBH onto immobilized artificial membrane (IAM) and glutaraldehyde-P (Glut-P) stationary phases.
- Development of coupled chromatography system with on-line extraction using a phenylboronic acid column.
- Investigation of enzyme activity, reproducibility, and effects of operational parameters (flow-rate, contact time, pH, temperature).
Main Results:
- Successfully developed enzymatically active and reproducible DBH-IMERs using IAM and Glut-P phases.
- Demonstrated the ability of DBH-IAM-IMER and DBH-Glut-P-IMER to characterize membrane-bound and cytosolic DBH forms, respectively.
- Validated the on-line system for investigating enzyme-substrate and enzyme-inhibitor interactions.
Conclusions:
- The developed DBH-IMERs provide a robust platform for studying DBH.
- The coupled chromatographic system enables efficient on-line characterization of DBH forms and interactions.
- These IMERs are valuable tools for the discovery and characterization of new drug candidates targeting DBH.